![]() |
RELATED RESOURCES |
SEC Filings:ENZNENZON PHARMACEUTICALS INC0.3275
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2020 | Form 10-Q* | Quarterly Report* | 07/29/2020 | 06/30/2020 |
Form 10-Q* | Quarterly Report* | 04/30/2020 | 03/31/2020 | |
2019 | Form 10-K/A* | Annual Report* | 04/24/2020 | 12/31/2019 |
2020 | Form SC 13D | Acquistion of beneficial ownership | 04/16/2020 | N/A |
Form 3 | Insider Initial Filing | 03/31/2020 | 03/18/2020 | |
Form 4/A | Insider Transaction | 03/31/2020 | 03/13/2020 | |
Form 4 | Insider Transaction | 03/27/2020 | 03/13/2020 | |
Form SC 13G/A | Beneficial Ownership Statement | 03/27/2020 | N/A | |
2019 | Form 10-K* | Annual Report* | 02/19/2020 | 12/31/2019 |
2020 | Form SC 13G/A | Beneficial Ownership Statement | 01/22/2020 | N/A |
Form SC 13G/A | Beneficial Ownership Statement | 01/16/2020 | N/A | |
2019 | Form 10-Q* | Quarterly Report* | 11/06/2019 | 09/30/2019 |
Form 8-K* | Current Report* | 08/22/2019 | 08/22/2019 | |
Form 10-Q* | Quarterly Report* | 08/07/2019 | 06/30/2019 | |
Form DEF 14A | Definitive Proxy Statements | 07/12/2019 | 08/22/2019 |